Event summary

Cooley is a proud sponsor of Life Sciences Patent Network (LSPN) North America Spring 2026. In an industry where robust intellectual property valuation and protection determine the success of biopharma and medtech companies at every stage, LSPN delivers the strategies, connections and knowledge that drive competitive advantage. This is where innovation meets protection, where global IP strategies are forged and where the future of life sciences IP is shaped.

Featured agenda item

Thursday, April 30, 2026 | 8:50 – 9:35 am

IP deal-making in life sciences: Valuation, due diligence and transaction strategies

Cooley partner John Rearick will moderate this panel covering:

  • IP due diligence best practices for life sciences M&A: Red flags and risk mitigation
  • Valuing platform technologies and emerging modalities: Practical approaches and methodologies
  • Licensing strategies for artificial intelligence-enabled drug discovery, gene editing and platform technologies
  • Structuring successful transactions: Term sheets, milestones and university tech transfer partnerships
  • Funding challenges and IP strategy in constrained capital markets

For more information, please email Laura Kettel.

Details and registration

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.